Published in Medicine and Law Weekly, July 25th, 2008
The appointment of Mr. Albright underscores Celsis' continuing commitment to educate and assist customers gain regulatory approval for implementing rapid detection methods, while also expanding Celsis' ability to work closely with regulatory agencies to further define the benefits of adopting rapid methods in the manufacture and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.